REVEALED: 6 | Vintage Vibes

Trump announces AstraZeneca will offer discount drugs on ‘TrumpRx’ website

TrumpRx.gov, a website where Americans can buy pharmaceutical drugs under President Donald Trump’s new drug pricing plan, is set to begin operation in 2026

The Independent UK · Oct 10, 2025

Trump Plans AstraZeneca Deal To Cut Drug Prices For Low-Income Americans

President Donald Trump is reportedly set to announce a new agreement with AstraZeneca Plc (NASDAQ:AZN) designed to reduce prescription drug costs for Americans.

Benzinga · Oct 10, 2025

AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs

AstraZeneca Plc (NASDAQ:AZN) on Thursday said it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader range of medicines, including cancer treatments.

Benzinga · Oct 9, 2025

FTSE 100 hits another high despite concerns over US government shutdown

Drug companies AstraZeneca, Hikma Pharmaceuticals and GSK were all big risers.

Evening Standard · Oct 1, 2025

The UK must invest in medicines – but not at any price

The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in medicines. He warned that the NHS risks losing out on important treatments and the country could lose its place at the cutting edge of medical research if spending does not recover. It comes…

The Conversation · Sep 30, 2025

AstraZeneca’s listing rejig spells long-term danger for London

It’s not skipping off entirely to New York, but pharma giant sets a worrying precedent for UK stock market

The Guardian - UK · Sep 29, 2025

AstraZeneca Moves From ADRs To NYSE Listing

The Board of AstraZeneca plc (NASDAQ: AZN) is recommending to shareholders a Harmonized Listing Structure for the company's ordinary shares across the London Stock Exchange (LSE), Nasdaq Stockholm (STO), and the New York Stock Exchange (NYSE).

Benzinga · Sep 29, 2025

AstraZeneca will list shares directly in New York, but isn't leaving the UK

Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.

Euronews · Sep 29, 2025

Emma Walmsley steps down as CEO of GSK as pharmaceutical industry faces upheaval

The drug and vaccine maker is a £60bn firm – one of the biggest in the UK

The Independent UK · Sep 29, 2025

GSK Switches CEO As Trump Tariffs Test Pharma

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.

International Business Times · Sep 29, 2025